Trastuzumab

Proper name: Trastuzumab
Tradename: Herceptin
Manufacturer: Genentech, Inc, South San Francisco, CA, License #1048
Indication for Use: Revised package insert to include updated median survival data
Approval Date: 12/11/2001
Type of submission: Biologics license application supplement

Approval Letter (PDF), (Text)

Label (PDF)

Last Updated: 1/23/2002

Back to Top     Back to Index

Updated: September 25, 2003

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

FDA/Center for Drug Evaluation and Research